AutoZone sees ability to grow sales across all lines in 2014 AutoZone CEO Bill Rhodes says 2013 investments will help sales grow in 2014 across all lines of business. Comment from Q4 earnings conference call.
News For AZO From The Last 14 Days
Check below for free stories on AZO the last two weeks.
AutoZone December volatility elevated into Q1 and sales outlook AutoZone December call option implied volatility at 27, January is at 20, March is at 19; compared to its 26-week average of 22 according to Track Data, suggesting large near term price movement into the expected release of Q1 results on December 10.
AutoZone price target raised to $500 from $450 at Barclays Barclays is confident AutoZone DIY comps improved in the quarter and continues to view shares as a deep value play given the buyback program. Shares are Overweight rated.
On The Fly: Analyst Downgrade Summary Today's noteworthy downgrades include: AutoZone (AZO) downgraded to Neutral from Buy at Goldman... Cardiovascular Systems (CSII) downgraded to Hold from Speculative Buy at Benchmark Co... DealerTrack (TRAK) downgraded to Underweight from Equal Weight at Barclays... Eldorado Gold (EGO) downgraded to Equal Weight from Overweight at Morgan Stanley... Francesca's (FRAN) downgraded to Neutral from Buy at Janney Capital... Freeport McMoRan (FCX) downgraded to Neutral from Buy at Goldman... IAMGOLD (IAG) downgraded to Underweight from Equal Weight at Morgan Stanley... Lionbridge (LIOX) downgraded to Neutral from Buy at B. Riley... Omega Protein (OME) downgraded to In-Line from Outperform at Imperial Capital... The Fresh Market (TFM) downgraded to Neutral from Buy at Goldman... Waters (WAT) downgraded to Neutral from Buy at Goldman... Weingarten Realty (WRI) downgraded to Market Perform from Outperform at Wells Fargo... Transocean (RIG) downgraded to Neutral from Add at Capital One... 21Vianet (VNET) downgraded to Sector Perform from Outperform at Pacific Crest... Nuance (NUAN) downgraded to Neutral from Outperform at Wedbush... Methanex (MEOH) downgraded to Market Perform from Outperform at Raymond James.